MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6505-1258-1268$20.00
Mol Pharmacol 65:1258-1268, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, A. P.
Right arrow Articles by Sitsapesan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, A. P.
Right arrow Articles by Sitsapesan, R.

Functional Regulation of the Cardiac Ryanodine Receptor by Suramin and Calmodulin Involves Multiple Binding Sites

Adam Parker Hill, Olivia Kingston, and Rebecca Sitsapesan

University of Bristol, Department of Pharmacology, School of Medical Sciences, Bristol United Kingdom (O.K., R.S.); and Imperial College School of Medicine, National Heart & Lung Institute, London, United Kingdom (A.P.H.)

Suramin and structurally related compounds increase not only the open probability (Po) of ryanodine receptor (RyR) channels but also the single-channel conductance in a unique characteristic manner. In this report, we examine the mechanisms underlying the complex changes to cardiac RyR channel function caused by suramin and the evidence that these changes result from an interaction with calmodulin (CaM) binding sites. In the presence of 100 µM cytosolic Ca2+, we demonstrate that suramin exerts a triphasic effect on Po, indicating the presence of high-, intermediate-, and low-affinity suramin binding sites. The effects of suramin binding to high-affinity sites are Ca2+-dependent; Po is decreased and seems to result from a reduction in the sensitivity of the channel to cytosolic Ca2+. We suggest that this site is the CaM inhibition site. Suramin also binds to intermediate-affinity sites that mediate an increase in Po and an increase in conductance. Cytosolic Ca2+ is not an absolute requirement for the effects mediated via intermediate-affinity suramin sites. The suramin-induced increase in Po and conductance are both concentration-dependent. The correlation between the increase in Po and increase in conductance indicates that the binding events which produce an increase in Po also lead to an increase in conductance and, because the effect is concentration-dependent, multiple suramin molecules must bind to produce the maximum effect. The low-affinity suramin binding sites are inhibition sites and mediate a reduction in Po caused by changes to both open and closed lifetimes.


Received August 18, 2003; accepted February 4, 2004

Address correspondence to: Dr. R. Sitsapesan, University of Bristol, Department of Pharmacology, School of Medical Sciences, University Walk, Bristol BS8 1TD, United Kingdom. E-mail: r.sitsapesan{at}bris.ac.uk




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Nadif Kasri, G. Bultynck, J. B. Parys, G. Callewaert, L. Missiaen, and H. De Smedt
Suramin and Disulfonated Stilbene Derivatives Stimulate the Ca2+-Induced Ca2+-Release Mechanism in A7r5 Cells
Mol. Pharmacol., July 1, 2005; 68(1): 241 - 250.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics